Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Terns Pharmaceuticals Inc (TERN)

Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Merck & Co.'s Quarterly Earnings Preview: What You Need to Know

Rahway, New Jersey-based Merck & Co., Inc. (MRK) is an international healthcare company that offers human health pharmaceuticals across various areas, including Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, and other brands. Valued at a market cap of $304.5 billion, the company is expected to release its Q1 2026 earnings on Thursday, Apr. 30, before the market opens.

Ahead of the event, analysts expect the company’s loss per share to be $0.58 on a diluted basis, down 126.1% from $2.22 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Fundamentals

See More
  • Market Capitalization, $K 6,077,649
  • Shares Outstanding, K 115,413
  • Annual Sales, $ 0 K
  • Annual Income, $ -96,210 K
  • EBIT $ -110 M
  • EBITDA $ -110 M
  • 60-Month Beta -0.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.42

Options Overview Details

View History
  • Implied Volatility 4.83% (-1.76%)
  • Historical Volatility 34.44%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 573.79% on 10/24/25
  • IV Low 4.83% on 04/09/26
  • Expected Move (DTE 8) 0.51 (0.97%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 2,232
  • Volume Avg (30-Day) 14,909
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 216,816
  • Open Int (30-Day) 110,882
  • Expected Range 52.10 to 53.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.30
  • Number of Estimates 3
  • High Estimate $-0.29
  • Low Estimate $-0.32
  • Prior Year $-0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.57 +20.76%
on 03/10/26
53.19 -1.08%
on 03/26/26
+8.33 (+18.80%)
since 03/09/26
3-Month
33.43 +57.39%
on 01/12/26
53.19 -1.08%
on 03/26/26
+17.14 (+48.29%)
since 01/09/26
52-Week
2.04 +2,479.17%
on 04/11/25
53.19 -1.08%
on 03/26/26
+50.32 (+2,187.61%)
since 04/09/25

Most Recent Stories

More News
Merck & Co.'s Quarterly Earnings Preview: What You Need to Know

Merck & Co. is expected to unveil its first-quarter results later this month, and analysts are projecting a triple-digit decline in profit.

XLV : 150.00 (+0.22%)
$SPX : 6,829.76 (+0.69%)
MRK : 123.17 (-0.01%)
TERN : 52.60 (-0.11%)
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceuticals,...

MRK : 123.17 (-0.01%)
TERN : 52.60 (-0.11%)
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted...

TERN : 52.60 (-0.11%)
Terns Pharmaceuticals: The Market Has Already Priced In Clinical Success Before Trial Data

Barchart Research What to Expect from TERN Earnings TERN Generated April 1, 2026 Current Price $52.79 EPS Estimate $$-0.29 Consensus Rating Moderate Buy Average Move 4.93% Terns Pharmaceuticals: The Market...

TERN : 52.60 (-0.11%)
Are TERN, CRBG, EQH Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TERN : 52.60 (-0.11%)
CRBG : 25.14 (+0.96%)
EQH : 38.69 (-0.39%)
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Terns Pharmaceuticals...

MRK : 123.17 (-0.01%)
TERN : 52.60 (-0.11%)
Merck Acquisition Overshadows Terns Pharmaceuticals Earnings as Biotech Reports Tomorrow

Barchart Research What to Expect from TERN Earnings TERN Generated March 25, 2026 Current Price $52.86 EPS Estimate $-0.29 Consensus Rating Strong Buy Average Move 4.93% Merck Acquisition Overshadows Terns...

TERN : 52.60 (-0.11%)
Stocks Finish Higher on US Push to End Iran War

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.54%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.67%. June E-mini...

SNDK : 836.33 (+7.10%)
RKLB : 68.71 (-0.54%)
TERN : 52.60 (-0.11%)
TXN : 215.39 (+3.11%)
$IUXX : 25,057.71 (+0.62%)
ZNM26 : 111-145 (+0.20%)
KBH : 52.60 (+2.31%)
ESM26 : 6,869.75 (+0.67%)
QCOM : 127.42 (-0.07%)
STX : 500.91 (+0.93%)
WDC : 338.51 (-0.08%)
AMD : 234.42 (+1.12%)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN)

NEW YORK , March 25, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

TERN : 52.60 (-0.11%)
Stocks Climb on Hopes of US-Iran Diplomacy

The S&P 500 Index ($SPX ) (SPY ) today is up +0.83%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.06%. June E-mini S&P futures (ESM26...

ALK : 39.94 (+0.08%)
MSTR : 131.08 (+2.17%)
UAL : 98.53 (+2.32%)
SNDK : 836.33 (+7.10%)
GLXY : 21.27 (+11.95%)
RKLB : 68.71 (-0.54%)
TERN : 52.60 (-0.11%)
TXN : 215.39 (+3.11%)
$IUXX : 25,057.71 (+0.62%)
COIN : 173.00 (-1.19%)
ZNM26 : 111-145 (+0.20%)
KBH : 52.60 (+2.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. Terns Pharmaceuticals Inc. is based in FOSTER CITY,...

See More

Key Turning Points

3rd Resistance Point 52.89
2nd Resistance Point 52.80
1st Resistance Point 52.73
Last Price 52.60
1st Support Level 52.57
2nd Support Level 52.48
3rd Support Level 52.41

See More

52-Week High 53.19
Last Price 52.60
Fibonacci 61.8% 33.65
Fibonacci 50% 27.61
Fibonacci 38.2% 21.58
52-Week Low 2.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.